Early increase in CSF levels of soluble PDGFRβ, degeneration of pericytes, and their coverage of brain capillaries have been shown in human and transgenic AD models on the APOE4 background [42, 47, 99, 100]. Here, PDGFRB is linked to Alzheimer disease.